How much funding has GreenLight Bio raised?

GreenLight Bio has raised $335.0M in total funding, most recently a Series C round.

Who are GreenLight Bio's investors?

GreenLight Bio's investors include Fall Line Capital, S2G Ventures, Morningside Group, Baird Capital, Just Climate, Environmental Impact Acquisition Corp.

When was GreenLight Bio founded?

GreenLight Bio was founded in 2008.

Where is GreenLight Bio headquartered?

GreenLight Bio is headquartered in Medford, Massachusetts, United States.

What industry is GreenLight Bio in?

GreenLight Bio operates in Biotech.

How many employees does GreenLight Bio have?

GreenLight Bio has 51-200 employees.

GreenLight Bio

IPO

GreenLight Biosciences

Medford, United States · Founded 2008 · $335.0M raised

Biotech

Headquarters: Medford, Massachusetts
Employees: 51–200
Founded: 2008
Business Model: B2B

Website: greenlightbiosciences.com
Total Funding: $335.0M
Last Round: $25.0M Series CMar 2025
Rounds: 9

About

GreenLight Biosciences is a biotech company founded in 2008 that uses a proprietary cell-free manufacturing platform to produce RNA-based solutions at scale. The company focuses on agricultural applications including biopesticides and crop protection, enabling more sustainable food production by replacing chemical pesticides with RNA-based alternatives for farmers and beekeepers.

Summary

GreenLight Bio is a Biotech company based in Medford, United States, founded in 2008. It has raised $335.0M in total across 9 rounds, most recently a $25.0M Series C round in Mar 2025. Investors include Fall Line Capital, S2G Ventures and Morningside Group.

LinkedIn X (Twitter)